Equities analysts expect that INC Research Holdings, Inc. (NASDAQ:INCR) will report $257.67 million in sales for the current quarter, Zacks reports. Eight analysts have issued estimates for INC Research Holdings’ earnings, with estimates ranging from $255.00 million to $263.00 million. INC Research Holdings posted sales of $258.80 million during the same quarter last year, which suggests a negative year over year growth rate of 0.4%. The business is scheduled to issue its next earnings results on Wednesday, July 26th.

According to Zacks, analysts expect that INC Research Holdings will report full-year sales of $257.67 million for the current fiscal year. For the next financial year, analysts expect that the firm will report sales of $1.16 billion per share, with estimates ranging from $1.15 billion to $1.17 billion. Zacks’ sales averages are an average based on a survey of analysts that follow INC Research Holdings.

INC Research Holdings (NASDAQ:INCR) last released its quarterly earnings data on Wednesday, May 10th. The company reported $0.60 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.55 by $0.05. The company had revenue of $252.10 million for the quarter, compared to analyst estimates of $250.76 million. INC Research Holdings had a return on equity of 43.17% and a net margin of 7.37%. The firm’s revenue for the quarter was up 1.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.58 earnings per share.

INCR has been the topic of several analyst reports. Jefferies Group LLC restated a “buy” rating and set a $51.00 price objective (down previously from $59.00) on shares of INC Research Holdings in a report on Tuesday, February 28th. Goldman Sachs Group, Inc. (The) cut INC Research Holdings from a “conviction-buy” rating to a “buy” rating and set a $51.00 price objective on the stock. in a report on Wednesday, March 1st. William Blair restated an “outperform” rating on shares of INC Research Holdings in a report on Wednesday, March 1st. Zacks Investment Research cut INC Research Holdings from a “buy” rating to a “hold” rating in a report on Tuesday, March 7th. Finally, SunTrust Banks, Inc. cut INC Research Holdings from a “buy” rating to a “hold” rating and set a $48.00 price objective on the stock. in a report on Monday, March 20th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $61.71.

In related news, CAO Christopher L. Gaenzle sold 4,733 shares of INC Research Holdings stock in a transaction on Monday, April 3rd. The stock was sold at an average price of $45.70, for a total value of $216,298.10. Following the transaction, the chief accounting officer now owns 53,050 shares in the company, valued at $2,424,385. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Alistair Macdonald sold 9,467 shares of INC Research Holdings stock in a transaction on Monday, May 1st. The shares were sold at an average price of $45.00, for a total value of $426,015.00. Following the completion of the transaction, the chief executive officer now owns 83,935 shares in the company, valued at approximately $3,777,075. The disclosure for this sale can be found here. 0.24% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of INCR. Envestnet Asset Management Inc. bought a new position in INC Research Holdings during the fourth quarter valued at approximately $109,000. Invictus RG bought a new position in INC Research Holdings during the first quarter valued at approximately $115,000. Foresters Investment Management Company Inc. bought a new position in INC Research Holdings during the first quarter valued at approximately $128,000. Fifth Third Bancorp raised its position in INC Research Holdings by 5.4% in the first quarter. Fifth Third Bancorp now owns 2,904 shares of the company’s stock valued at $133,000 after buying an additional 149 shares during the period. Finally, Ameritas Investment Partners Inc. bought a new position in INC Research Holdings during the first quarter valued at approximately $164,000. Hedge funds and other institutional investors own 98.70% of the company’s stock.

INC Research Holdings (INCR) traded up 0.42% during trading on Friday, reaching $59.45. The company’s stock had a trading volume of 1,974,629 shares. The company has a 50 day moving average price of $54.85 and a 200-day moving average price of $50.41. INC Research Holdings has a 52 week low of $36.70 and a 52 week high of $61.10. The company has a market capitalization of $3.22 billion, a PE ratio of 28.28 and a beta of 1.47.

TRADEMARK VIOLATION NOTICE: This report was published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another publication, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2017/06/23/257-67-million-in-sales-expected-for-inc-research-holdings-inc-incr-this-quarter.html.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Get a free copy of the Zacks research report on INC Research Holdings (INCR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.